The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins

Structure

Volumn 24, Issue 12, 2016, Pages 2043-2052

  Yatime, Laure ^a   Betzer, Cristine ^a   Jensen, Rasmus Kjeldsen ^a,b   Mortensen, Sofia ^a   Jensen, Poul Henning ^a   Andersen, Gregers Rom ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

pattern recognition receptor; RAGE; S100 proteins; signaling complex; stress response

Indexed keywords

CALCYCLIN; PATTERN RECOGNITION RECEPTOR; PROTEIN S 100; RAGE PROTEIN; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT RECEPTOR; AGER PROTEIN, HUMAN; CELL CYCLE PROTEIN; PROTEIN BINDING; S100A6 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DIMERIZATION; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; CHEMISTRY; METABOLISM; MOLECULAR MODEL; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; BINDING SITES; CELL CYCLE PROTEINS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; S100 PROTEINS; SIGNAL TRANSDUCTION;

EID: 85002681347     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2016.09.011     Document Type: Article

References (60)

1. Adams, P.D., Grosse-Kunstleve, R.W., Hung, L.W., Ioerger, T.R., McCoy, A.J., Moriarty, N.W., Read, R.J., Sacchettini, J.C., Sauter, N.K., Terwilliger, T.C., PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58 (2002), 1948–1954.
2. Arkhipov, A., Shan, Y., Das, R., Endres, N.F., Eastwood, M.P., Wemmer, D.E., Kuriyan, J., Shaw, D.E., Architecture and membrane interactions of the EGF receptor. Cell 152 (2013), 557–569.
3. Bjork, P., Bjork, A., Vogl, T., Stenstrom, M., Liberg, D., Olsson, A., Roth, J., Ivars, F., Leanderson, T., Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol., 7, 2009, e97.
4. Brodersen, D.E., Nyborg, J., Kjeldgaard, M., Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry 38 (1999), 1695–1704.
5. Chang, C.C., Khan, I., Tsai, K.L., Li, H., Yang, L.W., Chou, R.H., Yu, C., Blocking the interaction between S100A9 and RAGE V domain using CHAPS molecule: a novel route to drug development against cell proliferation. Biochim. Biophys. Acta 1864 (2016), 1558–1569.
6. Davis, I.W., Leaver-Fay, A., Chen, V.B., Block, J.N., Kapral, G.J., Wang, X., Murray, L.W., Arendall, W.B., Snoeyink, J., Richardson, J.S., et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35 (2007), W375–W383.
7. Donato, R., Cannon, B.R., Sorci, G., Riuzzi, F., Hsu, K., Weber, D.J., Geczy, C.L., Functions of S100 proteins. Curr. Mol. Med. 13 (2013), 24–57.
8. Emsley, P., Cowtan, K., Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60 (2004), 2126–2132.
9. Fritz, G., RAGE: a single receptor fits multiple ligands. Trends Biochem. Sci. 36 (2011), 625–632.
10. Hofmann, M.A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999), 889–901.
11. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J.X., Nagashima, M., Lundh, E.R., Vijay, S., Nitecki, D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270 (1995), 25752–25761.
12. Jensen, J.L., Indurthi, V.S., Neau, D.B., Vetter, S.W., Colbert, C.L., Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex. Acta Crystallogr. D Biol. Crystallogr. 71 (2015), 1176–1183.
13. Kabsch, W., Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 26 (1993), 795–800.
14. Kierdorf, K., Fritz, G., RAGE regulation and signaling in inflammation and beyond. J. Leukoc. Biol. 94 (2013), 55–68.
15. Koch, M., Chitayat, S., Dattilo, B.M., Schiefner, A., Diez, J., Chazin, W.J., Fritz, G., Structural basis for ligand recognition and activation of RAGE. Structure 18 (2010), 1342–1352.
16. Kordowska, J., Stafford, W.F., Wang, C.L., Ca2+ and Zn2+ bind to different sites and induce different conformational changes in human calcyclin. Eur. J. Biochem. 253 (1998), 57–66.
17. Krissinel, E., Henrick, K., Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372 (2007), 774–797.
18. Kuznicki, J., Filipek, A., Heimann, P., Kaczmarek, L., Kaminska, B., Tissue specific distribution of calcyclin–10.5 kDa Ca2+-binding protein. FEBS Lett. 254 (1989), 141–144.
19. Leclerc, E., Heizmann, C.W., The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine. Front. Biosci. 3 (2011), 1232–1262.
20. Leclerc, E., Fritz, G., Weibel, M., Heizmann, C.W., Galichet, A., S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 282 (2007), 31317–31331.
21. Leclerc, E., Fritz, G., Vetter, S.W., Heizmann, C.W., Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 1793 (2009), 993–1007.
22. Lee, Y.T., Dimitrova, Y.N., Schneider, G., Ridenour, W.B., Bhattacharya, S., Soss, S.E., Caprioli, R.M., Filipek, A., Chazin, W.J., Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognition. Biochemistry 47 (2008), 10921–10932.
23. Lesniak, W., Slomnicki, L.P., Filipek, A., S100A6-new facts and features. Biochem. Biophys. Res. Commun. 390 (2009), 1087–1092.
24. Lin, H., Andersen, G.R., Yatime, L., Structure of human S100A8 in the presence of calcium and zinc. BMC Struct. Biol., 16, 2016, 8.
25. Liu, R., Mori, S., Wake, H., Zhang, J., Liu, K., Izushi, Y., Takahashi, H.K., Peng, B., Nishibori, M., Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts: heparin's effect on binding. Acta Med. Okayama 63 (2009), 203–211.
26. Marenholz, I., Heizmann, C.W., Fritz, G., S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 322 (2004), 1111–1122.
27. McCoy, A.J., Grosse-Kunstleve, R.W., Storoni, L.C., Read, R.J., Likelihood-enhanced fast translation functions. Acta Crystallogr. D Biol. Crystallogr. 61 (2005), 458–464.
28. Mizumoto, S., Takahashi, J., Sugahara, K., Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells. J. Biol. Chem. 287 (2012), 18985–18994.
29. Mohan, S.K., Gupta, A.A., Yu, C., Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE). Biochem. Biophys. Res. Commun. 434 (2013), 328–333.
30. Moroz, O.V., Blagova, E.V., Wilkinson, A.J., Wilson, K.S., Bronstein, I.B., The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisation. J. Mol. Biol. 391 (2009), 536–551.
31. Moroz, O.V., Wilson, K.S., Bronstein, I.B., The role of zinc in the S100 proteins: insights from the X-ray structures. Amino Acids 41 (2011), 761–772.
32. Murray, J.I., Tonkin, M.L., Whiting, A.L., Peng, F., Farnell, B., Cullen, J.T., Hof, F., Boulanger, M.J., Structural characterization of S100A15 reveals a novel zinc coordination site among S100 proteins and altered surface chemistry with functional implications for receptor binding. BMC Struct. Biol., 12, 2012, 16.
33. Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C., Elliston, K., Stern, D., Shaw, A., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267 (1992), 14998–15004.
34. Ostendorp, T., Diez, J., Heizmann, C.W., Fritz, G., The crystal structures of human S100B in the zinc- and calcium-loaded state at three pH values reveal zinc ligand swapping. Biochim. Biophys. Acta 1813 (2011), 1083–1091.
35. Otterbein, L.R., Kordowska, J., Witte-Hoffmann, C., Wang, C.L., Dominguez, R., Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution. Structure 10 (2002), 557–567.
36. Penumutchu, S.R., Chou, R.H., Yu, C., Structural insights into calcium-bound S100P and the V domain of the RAGE complex. PLoS One, 9, 2014, e103947.
37. Rai, V., Maldonado, A.Y., Burz, D.S., Reverdatto, S., Yan, S.F., Schmidt, A.M., Shekhtman, A., Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J. Biol. Chem. 287 (2012), 5133–5144.
38. Rai, V., Toure, F., Chitayat, S., Pei, R., Song, F., Li, Q., Zhang, J., Rosario, R., Ramasamy, R., Chazin, W.J., et al. Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling. J. Exp. Med. 209 (2012), 2339–2350.
39. Rani, S.G., Sepuru, K.M., Yu, C., Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE). Biochim. Biophys. Acta 1844 (2014), 1718–1728.
40. Rezvanpour, A., Shaw, G.S., Unique S100 target protein interactions. Gen. Physiol. Biophys. 28 (2009), F39–F46.
41. Riehl, A., Nemeth, J., Angel, P., Hess, J., The receptor RAGE: bridging inflammation and cancer. Cell Commun. Signal., 7, 2009, 12.
42. Sakaguchi, M., Murata, H., Yamamoto, K., Ono, T., Sakaguchi, Y., Motoyama, A., Hibino, T., Kataoka, K., Huh, N.H., TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One, 6, 2011, e23132.
43. Salama, I., Malone, P.S., Mihaimeed, F., Jones, J.L., A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34 (2008), 357–364.
44. Sarkany, Z., Ikonen, T.P., Ferreira-da-Silva, F., Saraiva, M.J., Svergun, D., Damas, A.M., Solution structure of the soluble receptor for advanced glycation end products (sRAGE). J. Biol. Chem. 286 (2011), 37525–37534.
45. Sorci, G., Riuzzi, F., Giambanco, I., Donato, R., RAGE in tissue homeostasis, repair and regeneration. Biochim. Biophys. Acta 1833 (2013), 101–109.
46. Sparvero, L.J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A.A., Zeh, H.J., et al. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med., 7, 2009, 17.
47. Stern, D., Yan, S.D., Yan, S.F., Schmidt, A.M., Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 54 (2002), 1615–1625.
48. Tian, J., Avalos, A.M., Mao, S.Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8 (2007), 487–496.
49. Ulloa, L., Messmer, D., High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 17 (2006), 189–201.
50. Valkov, E., Stamp, A., Dimaio, F., Baker, D., Verstak, B., Roversi, P., Kellie, S., Sweet, M.J., Mansell, A., Gay, N.J., et al. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proc. Natl. Acad. Sci. USA 108 (2011), 14879–14884.
51. Wei, W., Lampe, L., Park, S., Vangara, B.S., Waldo, G.S., Cabantous, S., Subaran, S.S., Yang, D., Lakatta, E.G., Lin, L., Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis. PLoS One, 7, 2012, e50736.
52. Xie, J., Burz, D.S., He, W., Bronstein, I.B., Lednev, I., Shekhtman, A., Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 282 (2007), 4218–4231.
53. Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D.S., Shekhtman, A., Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J. Biol. Chem. 283 (2008), 27255–27269.
54. Xie, J., Mendez, J.D., Mendez-Valenzuela, V., Aguilar-Hernandez, M.M., Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal. 25 (2013), 2185–2197.
55. Xu, D., Young, J.H., Krahn, J.M., Song, D., Corbett, K.D., Chazin, W.J., Pedersen, L.C., Esko, J.D., Stable RAGE-heparan sulfate complexes are essential for signal transduction. ACS Chem. Biol. 8 (2013), 1611–1620.
56. Xue, J., Manigrasso, M., Scalabrin, M., Rai, V., Reverdatto, S., Burz, D.S., Fabris, D., Schmidt, A.M., Shekhtman, A., Change in the molecular dimension of a RAGE-ligand complex triggers RAGE signaling. Structure 24 (2016), 1509–1522.
57. Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J. Immunol. 186 (2011), 3248–3257.
58. Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996), 685–691.
59. Yan, S.F., Ramasamy, R., Naka, Y., Schmidt, A.M., Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ. Res. 93 (2003), 1159–1169.
60. Yatime, L., Andersen, G.R., Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products. FEBS J. 280 (2013), 6556–6568.